Your browser doesn't support javascript.
loading
Geministatins: new depside antibiotics from the fungus Austroacremonium gemini.
Crombie, Andrew; Kalaitzis, John A; Chen, Rachel; Vuong, Daniel; Lacey, Alastair E; Lacey, Ernest; Shivas, Roger G; Tan, Yu Pei; Sbaraini, Nicolau; Chooi, Yit-Heng; Piggott, Andrew M.
Afiliação
  • Crombie A; Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
  • Kalaitzis JA; School of Natural Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
  • Chen R; Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
  • Vuong D; Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
  • Lacey AE; Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
  • Lacey E; Microbial Screening Technologies, Smithfield, NSW, 2164, Australia.
  • Shivas RG; School of Natural Sciences, Macquarie University, Sydney, NSW, 2109, Australia.
  • Tan YP; Department of Agriculture and Fisheries, Plant Pathology Herbarium, Dutton Park, QLD, 4102, Australia.
  • Sbaraini N; Centre for Crop Health, University of Southern Queensland, Toowoomba, QLD, 4350, Australia.
  • Chooi YH; Department of Agriculture and Fisheries, Plant Pathology Herbarium, Dutton Park, QLD, 4102, Australia.
  • Piggott AM; Centre for Crop Health, University of Southern Queensland, Toowoomba, QLD, 4350, Australia.
J Antibiot (Tokyo) ; 2024 Jun 26.
Article em En | MEDLINE | ID: mdl-38926492
ABSTRACT
Two new depside antibiotics, geministatins A (1) and B (2), were isolated from the fungus Austroacremonium gemini MST-FP2131 (Sordariomycetes, Ascomycota), which was recovered from rotting wood in the wet tropics of northern Australia. The structures of the geministatins were elucidated by detailed spectroscopic analysis, chemical degradation and comparison with literature values. Chemical degradation of 1 and 2 yielded three new analogues, geministatins C-E (3-5), as well as a previously reported compound dehydromerulinic acid A (6). Compounds 1, 2 and 6 exhibited antibacterial activity against the Gram-positive bacteria Bacillus subtilis (MIC 0.2-1.6 µg mL-1) and Staphylococcus aureus (MIC 0.78-6.3 µg mL-1), including methicillin-resistant S. aureus (MRSA), while 4 exhibited antifungal activity against the yeast Saccharomyces cerevisiae (MIC 13 µg mL-1).

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Antibiot (Tokyo) Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Antibiot (Tokyo) Ano de publicação: 2024 Tipo de documento: Article